CSS
GH icon

Cubist Systematic Strategies’s Guardant Health GH Stock Holding History

Cubist Systematic Strategies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-329,322
Closed -$17.9M – 3205
2025
Q2 		$17.1M Buy
329,322
+269,575
+451% +$12M 0.08% 349
2025
Q1 		$2.55M Sell
59,747
-466,789
-89% -$20.1M 0.02% 1281
2024
Q4 		$16.1M Buy
+526,536
New +$14.8M 0.1% 290
2024
Q3 		– Sell
-374,130
Closed -$10.6M – 3170
2024
Q2 		$10.8M Buy
374,130
+308,621
+471% +$7.19M 0.07% 365
2024
Q1 		$1.35M Sell
65,509
-288,985
-82% -$6.19M 0.01% 1926
2023
Q4 		$9.59M Buy
+354,494
New +$9.3M 0.06% 473
2023
Q2 		– Sell
-647,776
Closed -$18.6M – 3806
2023
Q1 		$15.2M Buy
647,776
+350,632
+118% +$10M 0.09% 248
2022
Q4 		$8.08M Buy
297,144
+287,213
+2,892% +$13.1M 0.05% 629
2022
Q3 		$535K Sell
9,931
-5,111
-34% -$262K ﹤0.01% 3115
2022
Q2 		$607K Sell
15,042
-3,931
-21% -$195K ﹤0.01% 2899
2022
Q1 		$1.26M Buy
18,973
+16,079
+556% +$1.1M 0.01% 1852
2021
Q4 		$289K Buy
+2,894
New +$299K ﹤0.01% 2821
2021
Q3 		– Sell
-41,495
Closed -$5.15M – 3032
2021
Q2 		$5.15M Buy
+41,495
New +$5.58M 0.06% 524
2021
Q1 		– Sell
-85,271
Closed -$11M – 2882
2020
Q4 		$11M Buy
85,271
+60,259
+241% +$6.93M 0.15% 130
2020
Q3 		$2.8M Buy
25,012
+17,687
+241% +$1.62M 0.04% 702
2020
Q2 		$594K Buy
7,325
+2,425
+49% +$195K 0.01% 1498
2020
Q1 		$341K Buy
4,900
+3,935
+408% +$302K 0.01% 1449
2019
Q4 		$75K Sell
965
-78,465
-99% -$5.65M ﹤0.01% 2239
2019
Q3 		$5.07M Buy
79,430
+70,435
+783% +$6.21M 0.1% 287
2019
Q2 		$777K Buy
8,995
+7,333
+441% +$560K 0.01% 1180
2019
Q1 		$127K Buy
+1,662
New +$92.1K ﹤0.01% 1942

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's GH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Guardant Health (GH) in Q3 2025, closing a stake of 329,322 shares — an estimated $17.9M sold.

Cubist Systematic Strategies first reported a position in GH in Q1 2019 and held it in 21 quarters. The position peaked at $17.1M in Q2 2025. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 329,322 Guardant Health shares in Q3 2025, an estimated $17.9M.
  • Cubist Systematic Strategies first reported a position in Guardant Health in Q1 2019 and held it in 21 quarters.
  • Cubist Systematic Strategies's Guardant Health position peaked at $17.1M in Q2 2025.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.